The Prenatalsafe® 3 screening test detects the aneuploidy of chromosomes 21, 18, 13 (Trisomy 21 - Down Syndrome, Trisomy 18 - Edwards Syndrome, Trisomy 13 - Patau Syndrome) and includes the determination of fetal sex (optional).
The Prenatalsafe® 5 screening test detects the aneuploidy of chromosomes 21, 18, 13 and sex chromosomes (Monosomy X - Turner Syndrome, XXY - Klinefelter Syndrome, XYY - Jacobs Syndrome), and includes the determination of fetal sex (optional).
In addition to the aneuploidy of chromosomes 21, 18, 13 and of the sex chromosomes (X and Y), the Prenatalsafe® Plus screening test also detects chromosomal trisomy 9 and 16 (optional) as well as sub-microscopic structures, such as some common microdeletion syndromes.
With Prenatalsafe® Karyo screening test detects aneuploidy on all chromosomes with results similar to an invasive analysis of the karyotype.
Prenatalsafe® Complete combines the findings of Prenatalsafe® Karyo and mutations responsible for serious genetic diseases (5 hereditary and 44 recessive de novo).
PrenatalsafeE® Complete Plus allows the findings of Prenatalsafe® Complete and the 9 most common microdeletion syndromes.